

NCT03253796 Raw comparison:

Summary:
CHIA has 45 criteria while your personal folder has 56 criteria
Total found criteria: 40/45
Total not Found: 5/45
Total Extra: 11
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Is not of reproductive potential or is of          │ Is not of reproductive potential or is of          │
│ reproductive potential and agrees to avoid         │ reproductive potential and agrees to avoid         │
│ becoming pregnant or impregnating a partner while  │ becoming pregnant or impregnating a partner while  │
│ receiving trial medication or within 6 months      │ receiving trial medication or within 6 months      │
│ after the last dose of trial medication            │ after the last dose of trial medication            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has chronic back pain of =3 months duration by     │ Has chronic back pain of ≥3 months duration by     │
│ history                                            │ history                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Inflammatory back pain                           │ Inflammatory back pain                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Arthritis (physician-diagnosed)                  │ Arthritis (physician-diagnosed)                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Enthesitis (heel) physician-diagnosed            │ Enthesitis (heel) physician-diagnosed (spontaneous │
│ (spontaneous pain or tenderness at examination of  │ pain or tenderness at examination of the site of   │
│ the site of the insertion of the Achilles tendon   │ the insertion of the Achilles tendon or plantar    │
│ or plantar fascia)                                 │ fascia)                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Dactylitis (physician-diagnosed)                 │ Dactylitis (physician-diagnosed)                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Psoriasis (physician-diagnosed)                  │ Psoriasis (physician-diagnosed)                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • History of physician-diagnosed inflammatory      │ History of physician-diagnosed inflammatory bowel  │
│ bowel disease (IBD)                                │ disease (IBD)                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • History of uveitis confirmed by an               │ History of uveitis confirmed by an ophthalmologist │
│ ophthalmologist                                    │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Good response to nonsteroidal anti-inflammatory  │ Good response to nonsteroidal anti-inflammatory    │
│ drugs (NSAID)                                      │ drugs (NSAID)                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Family history of SpA (presence of ankylosing    │ Family history of SpA (presence of ankylosing      │
│ spondylitis psoriasis acute uveitis reactive       │ spondylitis psoriasis acute uveitis reactive       │
│ arthritis or IBD)                                  │ arthritis or IBD)                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Human leukocyte antigen B27 (HLA-B27)+ gene      │ Human leukocyte antigen B27 (HLA-B27)+ gene OR     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has elevated CRP at Screening or evidence of       │ Has elevated CRP at Screening or evidence of       │
│ active inflammation in the sacroiliac joints on    │ active inflammation in the sacroiliac joints on    │
│ MRI                                                │ MRI                                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Shows high disease activity at Screening and       │ Shows high disease activity at Screening and       │
│ Baseline of both a Total Back Pain score of =4 and │ Baseline of both a Total Back Pain score of ≥4 and │
│ a Bath Ankylosing Spondylitis Disease Activity     │ a Bath Ankylosing Spondylitis Disease Activity     │
│ Index (BASDAI) score of >= 4                       │ Index (BASDAI) score of \>= 4                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has an acceptable history of NSAID use             │ Has an acceptable history of NSAID use             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has no history of untreated latent or active       │ Has no history of untreated latent or active       │
│ tuberculosis (TB) prior to Screening               │ tuberculosis (TB) prior to Screening               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has had no recent close contact with a person with │ Has had no recent close contact with a person with │
│ active TB or if there has been such contact will   │ active TB or if there has been such contact will   │
│ undergo additional evaluations and receive         │ undergo additional evaluations and receive         │
│ appropriate treatment for latent TB                │ appropriate treatment for latent TB                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Is a nursing or pregnant female or intends to      │ Is a nursing or pregnant female or intends to      │
│ become pregnant within 6 months after receiving    │ become pregnant within 6 months after receiving    │
│ trial medication                                   │ trial medication                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Intends to donate eggs (female participants) or    │ Intends to donate eggs (female participants) or    │
│ sperm (male participants) while receiving trial    │ sperm (male participants) while receiving trial    │
│ medication or within 6 months after trial          │ medication or within 6 months after trial          │
│ medication                                         │ medication                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has any clinically significant condition or        │ Has any clinically significant condition or        │
│ situation that would interfere with the trial      │ situation that would interfere with the trial      │
│ evaluations or participation in the trial          │ evaluations or participation in the trial          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has ever received any cytotoxic drugs including    │ Has ever received any cytotoxic drugs including    │
│ chlorambucil cyclophosphamide nitrogen mustard or  │ chlorambucil cyclophosphamide nitrogen mustard or  │
│ other alkylating agents                            │ other alkylating agents                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Disease-modifying anti-rheumatic drugs (30 days  │ • Disease-modifying anti-rheumatic drugs (30 days  │
│ off drug)                                          │ off drug)                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Live vaccinations (3 months off drug)            │ • Live vaccinations (3 months off drug)            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Investigational medications (30 days or 5 half-  │ • Investigational medications (30 days or 5 half-  │
│ lives off drug whichever is longer)                │ lives off drug whichever is longer)                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ • Bacille Calmette-Guerin (BCG) vaccination (12    │ • Bacille Calmette-Guerin (BCG) vaccination (12    │
│ months off drug)                                   │ months off drug)                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has any systemic inflammatory condition including  │ Has any systemic inflammatory condition including  │
│ psoriatic arthritis active Lyme disease systemic   │ psoriatic arthritis active Lyme disease systemic   │
│ lupus erythematosus infectious arthritis           │ lupus erythematosus infectious arthritis           │
│ vasculitis parvovirus infection rheumatoid         │ vasculitis parvovirus infection rheumatoid         │
│ arthritis active uveitis or active IBD             │ arthritis active uveitis or active IBD             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has a history of latent or active granulomatous    │ Has a history of latent or active granulomatous    │
│ infection prior to Screening                       │ infection prior to Screening                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Had a nontuberculous mycobacterial infection or    │ Had a nontuberculous mycobacterial infection or    │
│ opportunistic infection within 6 months prior to   │ opportunistic infection within 6 months prior to   │
│ Screening                                          │ Screening                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has a history of an infected joint prosthesis or   │ Has a history of an infected joint prosthesis or   │
│ has received antibiotics for a suspected infection │ has received antibiotics for a suspected infection │
│ of a joint prosthesis if that prosthesis has not   │ of a joint prosthesis if that prosthesis has not   │
│ been removed or replaced                           │ been removed or replaced                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Had a serious infection has been hospitalized for  │ Had a serious infection has been hospitalized for  │
│ an infection or has been treated with IV           │ an infection or has been treated with IV           │
│ antibiotics for an infection within 2 months prior │ antibiotics for an infection within 2 months prior │
│ to Baseline                                        │ to Baseline                                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Had a history of or ongoing chronic or recurrent   │ Had a history of or ongoing chronic or recurrent   │
│ infectious disease                                 │ infectious disease                                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Is known to be infected with human                 │ Is known to be infected with human                 │
│ immunodeficiency virus (HIV) or seropositive for   │ immunodeficiency virus (HIV) or seropositive for   │
│ hepatitis C virus (HCV)                            │ hepatitis C virus (HCV)                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has had a chest x-ray within 2 months prior to     │ Has had a chest x-ray within 2 months prior to     │
│ Screening that shows an abnormality suggestive of  │ Screening that shows an abnormality suggestive of  │
│ a current active infection or malignancy           │ a current active infection or malignancy           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has a history of lymphoproliferative disease       │ Has a history of lymphoproliferative disease       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has had a malignancy within 5 years before         │ Has had a malignancy within 5 years before         │
│ screening (exceptions are squamous and basal cell  │ screening (exceptions are squamous and basal cell  │
│ carcinomas of the skin and carcinoma in situ of    │ carcinomas of the skin and carcinoma in situ of    │
│ cervix that has been surgically cured)             │ cervix that has been surgically cured)             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has a history of known demyelinating diseases such │ Has a history of known demyelinating diseases such │
│ as multiple sclerosis or optic neuritis            │ as multiple sclerosis or optic neuritis            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has a history of or concurrent congestive heart    │ Has a history of or concurrent congestive heart    │
│ failure of any grade                               │ failure of any grade                               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has a transplanted organ (with the exception of a  │ Has a transplanted organ (with the exception of a  │
│ corneal transplant performed >= 3 months prior to  │ corneal transplant performed \>= 3 months prior to │
│ baseline)                                          │ baseline)                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Has current signs or symptoms of significant       │ Has current signs or symptoms of significant       │
│ medical illness which could interfere with the     │ medical illness which could interfere with the     │
│ trial or require treatment that might interfere    │ trial or require treatment that might interfere    │
│ with the trial                                     │ with the trial                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Is a user of recreational or illicit drugs or has  │ Is a user of recreational or illicit drugs or has  │
│ or had a substance abuse (drug or alcohol) problem │ or had a substance abuse (drug or alcohol) problem │
│ within the previous 2 years                        │ within the previous 2 years                        │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒══════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                              │
╞══════════════════════════════════════════════════════════════════════════════════╡
│ Has physician-diagnosed active nr-axSpA with disease duration <= 5 years         │
├──────────────────────────────────────────────────────────────────────────────────┤
│ • Elevated CRP                                                                   │
├──────────────────────────────────────────────────────────────────────────────────┤
│ Has a HLA-B27+ gene and 2 or more of the SpA characteristics listed above        │
├──────────────────────────────────────────────────────────────────────────────────┤
│ Has an ASDAS >= 2 1 at Screening                                                 │
├──────────────────────────────────────────────────────────────────────────────────┤
│ Has bilateral sacroiliitis Grade 2 or unilateral sacroiliitis Grade 3 or Grade 4 │
╘══════════════════════════════════════════════════════════════════════════════════╛



╒═══════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                           │
╞═══════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Has an Ankylosing Spondylitis Disease Activity Score (ASDAS) \>= 2 1 at Screening                 │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Meets one of the following criteria                                                               │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have maximum age of 45 Years                                                                 │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Has active inflammation on magnetic resonance imaging (MRI) highly suggestive of sacroiliitis     │
│ associated with spondyloarthropathy and 1 or more of the following spondyloarthritis (SpA)        │
│ characteristics                                                                                   │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Has bilateral sacroiliitis Grade 2 or unilateral sacroiliitis Grade 3 or Grade 4 on conventional  │
│ x-rays                                                                                            │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Has received any treatment listed below more recently than the indicated off-drug period prior to │
│ Screening                                                                                         │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Has a HLA-B27+ gene and 2 or more of the following SpA characteristics                            │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                 │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Agrees to undergo screening for hepatitis B virus (HBV) and demonstrates negative results for     │
│ hepatitis B surface antigen (HBsAg) and HBV deoxyribonucleic acid (DNA)                           │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Has physician-diagnosed active non-radiographic axial spondyloarthritis (nr-axSpA) with disease   │
│ duration \<= 5 years                                                                              │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Elevated C-reactive protein (CRP)                                                                 │
╘═══════════════════════════════════════════════════════════════════════════════════════════════════╛